- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Childhood acute lymphoblastic leukaemia and surveillance regimes
2021.10.26 |
| Date | Fri 05 Nov |
| Time | 14:00 — 16:00 |
| Location | Auditorium C114-101, Entrance C, C110, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N |
On Friday 5 November at 14:00, Karen Schow Jensen defends her dissertation entitled "Childhood acute lymphoblastic leukaemia and surveillance regimes".
Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer and a disease for which most children are cured. For decades, the survival rate has followed a positive trend, and now more than 90% of children are alive five years after their diagnosis. The primary obstacle to event-free survival being a relapse. The risk of relapse is highest within the first years after diagnosis. Therefore, it has been routine in most countries to follow-up patients in the outpatient clinic every one or two months during the first years after end of therapy for ALL in order to detect relapse and possible late effects at an early stage. However, little evidence is available on the value of these follow-up programmes concerning detection of relapse and survival.
With the overall purpose of evidence-based short-term surveillance programs for childhood ALL survivors, this PhD project explored the relapse burden, relapse detection mode, the longitudinal excess health care utilisation and the changes in health care utilisation before the diagnosis of a relapse.
The summary is written by the PhD student.
The defence is public and takes place in Auditorium C114-101, Entrance C, C110, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N. Please read full press release for more information.
PhD student Karen Schow Jensen
Mail: karenschowjensen@clin.au.dk
Phone: (+45) 6171 8432